ASGE Interventional IBD: Management of Complications (On-Demand)| March 2022-Update of Medical Management of Ulcerative Colitis and Crohn's Disease

Update of Medical Management of Ulcerative Colitis and Crohn's Disease

Video Transcription

Video Summary

In this video, Dr. David Rubin provides an update on the medical management of ulcerative colitis (UC) and Crohn's disease. He emphasizes the importance of clarifying the diagnosis of IBD and expanding it to include elements of prognosis and assessment of traditional and emerging extraintestinal manifestations. The goals of management include inducing remission, achieving objective evidence of inflammation control, and moving to the maintenance phase focused on prevention of relapse and progression. Dr. Rubin discusses the evolving understanding of the chronic phase and the importance of preventing complications and developing customized monitoring strategies. He highlights the increasing treatment options available, including synthetic targeted small molecules like tofacitinib and osonoamide. The use of treat-to-target strategies, combination therapies, and monitoring strategies are also discussed. Dr. Rubin concludes by mentioning the ongoing research in the field and the potential for microbiome-based maintenance therapies in the future. Overall, he provides valuable insights and recommendations for managing UC and Crohn's disease effectively.

Asset Subtitle

David T. Rubin, MD, FASGE

Keywords

ulcerative colitis

Crohn's disease

medical management

diagnosis

treatment options

monitoring strategies